VICP Registry Case Source Bundle Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_24-vv-01101 Package ID: USCOURTS-cofc-1_24-vv-01101 Petitioner: Mary O. Lilly Filed: 2024-07-19 Decided: 2025-03-11 Vaccine: human papillomavirus (HPV) Vaccination date: 2022-06-24 Condition: vasovagal syncope with facial injury and avulsion of right central incisor tooth Outcome: compensated Award amount USD: 53418.66 AI-assisted case summary: On July 19, 2024, Mary O. Lilly filed a petition alleging that she experienced vasovagal syncope after receiving a human papillomavirus vaccine on June 24, 2022. The public rulings identify the resulting injuries as facial injury with swelling and headache, along with avulsion of her right central incisor tooth. Respondent conceded entitlement in a Rule 4(c) report, agreeing that the record satisfied the Vaccine Injury Table for vasovagal syncope and that no alternative cause explained the event. Chief Special Master Brian H. Corcoran found entitlement on January 10, 2025. The public decisions do not provide a detailed emergency-room or dental-treatment chronology beyond the syncope and injury descriptions. On March 11, 2025, Chief Special Master Corcoran adopted respondent's damages proffer. Ms. Lilly was awarded $50,000.00 for pain and suffering and $3,418.66 in unreimbursed expenses, for a total lump sum of $53,418.66. Theory of causation field: HPV vaccine June 24, 2022 causing Table vasovagal syncope with facial injury/swelling/headache and avulsion of right central incisor; adult, exact age not stated; onset same day. ENTITLEMENT CONCEDED; COMPENSATED. Respondent conceded Table syncope and no alternative cause. Award $50,000 pain/suffering + $3,418.66 expenses = $53,418.66. Chief SM Brian H. Corcoran; petition July 19, 2024; entitlement January 10, 2025; damages March 11, 2025. Public staged source text: ================================================================================ DOCUMENT 1: USCOURTS-cofc-1_24-vv-01101-0 Date issued/filed: 2025-02-10 Pages: 2 Docket text: PUBLIC ORDER/RULING (Originally filed: 01/10/2025) regarding 14 Ruling on Entitlement Signed by Chief Special Master Brian H. Corcoran. (ppa) Service on parties made. -------------------------------------------------------------------------------- Case 1:24-vv-01101-UNJ Document 16 Filed 02/10/25 Page 1 of 2 In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 24-1101V MARY O. LILLY, Chief Special Master Corcoran Petitioner, v. Filed: January 10, 2025 SECRETARY OF HEALTH AND HUMAN SERVICES, Respondent. Paul D. Bekman, Bekman, Marder, Hopper, Malarkey & Perlin, LLC, Baltimore, MD, for Petitioner. Jeremy Mauritzen, U.S. Department of Justice, Washington, DC, for Respondent. RULING ON ENTITLEMENT1 On July 19, 2024, Mary O. Lilly filed a petition for compensation under the National Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10, et seq. (the “Vaccine 1 Act”). Petitioner alleges that she suffered a syncopal episode upon receiving a human papillomavirus (“HPV”) vaccine on June 24, 2022, which resulted in injuries including “a facial injury resulting in swelling and headache, and avulsion of the right, central incisor tooth.” Petition at 2. The case was assigned to the Special Processing Unit of the Office of Special Masters. On January 8, 2025, Respondent filed his Rule 4(c) report in which he concedes that Petitioner is entitled to compensation in this case. Rule 4(c) Report at 1. Specifically, Respondent agrees that Petitioner satisfies the criteria set forth in the Vaccine Injury Table (the “Table”), and the accompanying Qualifications and Aids to Interpretation (“QAI”), which afford Petitioner a presumption of causation if the onset of vasovagal syncope occurs within one hour after an HPV vaccination, and there is no apparent 1 Because this Ruling contains a reasoned explanation for the action taken in this case, it must be made publicly accessible and will be posted on the United States Court of Federal Claims' website, and/or at https://www.govinfo.gov/app/collection/uscourts/national/cofc, in accordance with the E-Government Act of 2002. 44 U.S.C. § 3501 note (2018) (Federal Management and Promotion of Electronic Government Services). This means the Ruling will be available to anyone with access to the internet. In accordance with Vaccine Rule 18(b), Petitioner has 14 days to identify and move to redact medical or other information, the disclosure of which would constitute an unwarranted invasion of privacy. If, upon review, I agree that the identified material fits within this definition, I will redact such material from public access. Case 1:24-vv-01101-UNJ Document 16 Filed 02/10/25 Page 2 of 2 alternative cause. Id. at 2 (citing 42 C.F.R. §§ 100.3(a)(XVI)(C), (c)(13)). Respondent also agrees that Petitioner experienced more than six months of residual effects of this injury. Id. In view of Respondent’s position and the evidence of record, I find that Petitioner is entitled to compensation. IT IS SO ORDERED. s/Brian H. Corcoran Brian H. Corcoran Chief Special Master 2 ================================================================================ DOCUMENT 2: USCOURTS-cofc-1_24-vv-01101-cl-extra-10796790 Date issued/filed: 2025-02-10 Pages: 1 Docket text: Supplementary opinion from CourtListener cluster 10330202 -------------------------------------------------------------------------------- In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 24-1101V MARY O. LILLY, Chief Special Master Corcoran Petitioner, v. Filed: January 10, 2025 SECRETARY OF HEALTH AND HUMAN SERVICES, Respondent. Paul D. Bekman, Bekman, Marder, Hopper, Malarkey & Perlin, LLC, Baltimore, MD, for Petitioner. Jeremy Mauritzen, U.S. Department of Justice, Washington, DC, for Respondent. RULING ON ENTITLEMENT1 On July 19, 2024, Mary O. Lilly filed a petition for compensation under the National Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10, et seq.1 (the “Vaccine Act”). Petitioner alleges that she suffered a syncopal episode upon receiving a human papillomavirus (“HPV”) vaccine on June 24, 2022, which resulted in injuries including “a facial injury resulting in swelling and headache, and avulsion of the right, central incisor tooth.” Petition at 2. The case was assigned to the Special Processing Unit of the Office of Special Masters. On January 8, 2025, Respondent filed his Rule 4(c) report in which he concedes that Petitioner is entitled to compensation in this case. Rule 4(c) Report at 1. Specifically, Respondent agrees that Petitioner satisfies the criteria set forth in the Vaccine Injury Table (the “Table”), and the accompanying Qualifications and Aids to Interpretation (“QAI”), which afford Petitioner a presumption of causation if the onset of vasovagal syncope occurs within one hour after an HPV vaccination, and there is no apparent 1 Because this Ruling contains a reasoned explanation for the action taken in this case, it must be made publicly accessible and will be posted on the United States Court of Federal Claims' website, and/or at https://www.govinfo.gov/app/collection/uscourts/national/cofc, in accordance with the E-Government Act of 2002. 44 U.S.C. § 3501 note (2018) (Federal Management and Promotion of Electronic Government Services). This means the Ruling will be available to anyone with access to the internet. In accordance with Vaccine Rule 18(b), Petitioner has 14 days to identify and move to redact medical or other information, the disclosure of which would constitute an unwarranted invasion of privacy. If, upon review, I agree that the identified material fits within this definition, I will redact such material from public access. alternative cause. Id. at 2 (citing 42 C.F.R. §§ 100.3(a)(XVI)(C), (c)(13)). Respondent also agrees that Petitioner experienced more than six months of residual effects of this injury. Id. In view of Respondent’s position and the evidence of record, I find that Petitioner is entitled to compensation. IT IS SO ORDERED. s/Brian H. Corcoran Brian H. Corcoran Chief Special Master 2 ================================================================================ DOCUMENT 3: USCOURTS-cofc-1_24-vv-01101-1 Date issued/filed: 2025-04-10 Pages: 5 Docket text: PUBLIC DECISION (Originally filed: 03/11/2025) regarding 20 DECISION Stipulation/Proffer Signed by Chief Special Master Brian H. Corcoran. (ppa) Service on parties made. -------------------------------------------------------------------------------- Case 1:24-vv-01101-UNJ Document 27 Filed 04/10/25 Page 1 of 5 In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 24-1101V MARY O. LILLY, Chief Special Master Corcoran Petitioner, v. Filed: March 11, 2025 SECRETARY OF HEALTH AND HUMAN SERVICES, Respondent. Paul D. Bekman, Bekman, Marder, Hopper, Malarkey & Perlin, LLC, Baltimore, MD, for Petitioner. Jeremy Mauritzen, U.S. Department of Justice, Washington, DC, for Respondent. DECISION ON DAMAGES1 On July 19, 2024, Mary O. Lilly filed a petition for compensation under the National Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10, et seq. (the “Vaccine 1 Act”). Petitioner alleges that she suffered a syncopal episode upon receiving a human papillomavirus (“HPV”) vaccine on June 24, 2022, which resulted in injuries including “a facial injury resulting in swelling and headache, and avulsion of the right, central incisor tooth.” Petition at 2. The case was assigned to the Special Processing Unit of the Office of Special Masters. On January 10, 2025, a Ruling on Entitlement was issued, finding Petitioner entitled to compensation for a Table vasovagal syncope injury. On March 10, 2025, Respondent filed a Proffer on award of compensation (“Proffer”). Respondent represented that Petitioner agrees with the proffered award. Id. at 2. Based on the record as a whole, I find that Petitioner is entitled to an award as stated in the Proffer. 1 Because this Decision contains a reasoned explanation for the action taken in this case, it must be made publicly accessible and will be posted on the United States Court of Federal Claims' website, and/or at https://www.govinfo.gov/app/collection/uscourts/national/cofc, in accordance with the E-Government Act of 2002. 44 U.S.C. § 3501 note (2018) (Federal Management and Promotion of Electronic Government Services). This means the Decision will be available to anyone with access to the internet. In accordance with Vaccine Rule 18(b), Petitioner has 14 days to identify and move to redact medical or other information, the disclosure of which would constitute an unwarranted invasion of privacy. If, upon review, I agree that the identified material fits within this definition, I will redact such material from public access. Case 1:24-vv-01101-UNJ Document 27 Filed 04/10/25 Page 2 of 5 Pursuant to the terms stated in the attached proffer, Petitioner is awarded a lump sum of $53,418.66 (representing $50,000.00 for pain and suffering, and $3,418.66 for past unreimbursable expenses), to be paid through an ACH deposit to Petitioner’s counsel’s IOLTA account for prompt disbursement to Petitioner. Proffer at 2. This amount represents compensation for all damages that would be available under Section 15(a). Id. The Clerk of Court is directed to enter judgment in accordance with this decision.2 IT IS SO ORDERED. s/Brian H. Corcoran Brian H. Corcoran Chief Special Master 2 Pursuant to Vaccine Rule 11(a), entry of judgment can be expedited by the parties’ joint filing of notice renouncing the right to seek review. 2 Case 1:24-vv-01101-UNJ Document 27 Filed 04/10/25 Page 3 of 5 IN THE UNITED STATES COURT OF FEDERAL CLAIMS OFFICE OF SPECIAL MASTERS MARY O. LILLY, Petitioner, v. No. 24-1101V Chief Special Master Corcoran SECRETARY OF HEALTH AND ECF HUMAN SERVICES, Respondent. RESPONDENT’S PROFFER ON AWARD OF COMPENSATION On July 19, 2024, Mary O. Lilly (“petitioner”) filed a petition for compensation under the National Childhood Vaccine Injury Act of 1986, 42 U.S.C. §§ 300aa-1 to -34 (“Vaccine Act” or “Act”), alleging that she suffered a syncopal episode following administration of a Human Papillomavirus (“HPV”) vaccine she received on June 24, 2022. Petition at 1. On January 8, 2025, the Secretary of Health and Human Services (“respondent”) filed a Rule 4(c) Report indicating that this case is appropriate for compensation under the terms of the Act for a vasovagal syncope Table injury, and on January 10, 2025, the Chief Special Master issued a Ruling on Entitlement finding petitioner entitled to compensation. ECF No. 13; ECF No. 14. I. Items of Compensation A. Pain and Suffering Respondent proffers that petitioner should be awarded $50,000 in pain and suffering. See 42 U.S.C. § 300aa-15(a)(4). Petitioner agrees. Case 1:24-vv-01101-UNJ Document 27 Filed 04/10/25 Page 4 of 5 B. Past Unreimbursable Expenses Evidence supplied by petitioner documents that she incurred past unreimbursable expenses related to her vaccine-related injury. Respondent proffers that petitioner should be awarded past unreimbursable expenses in the amount of $3,418.66. See 42 U.S.C. § 300aa- 15(a)(1)(B). Petitioner agrees. These amounts represent all elements of compensation to which petitioner is entitled under 42 U.S.C. § 300aa-15(a). Petitioner agrees. II. Form of the Award Petitioner is a competent adult. Evidence of guardianship is not required in this case. Respondent recommends that the compensation provided to petitioner should be made through a lump sum payment as described below and requests that the Chief Special Master’s decision and the Court’s judgment award the following1: a lump sum payment of $53,418.66 to be paid through an ACH deposit to petitioner’s counsel’s IOLTA account for prompt disbursement to petitioner. III. Summary of Recommended Payment Following Judgment Lump sum payable to petitioner, Mary O. Lilly: $53,418.66 Respectfully submitted, YAAKOV ROTH Acting Assistant Attorney General C. SALVATORE D’ALESSIO Director Torts Branch, Civil Division 1 Should petitioner die prior to entry of judgment, the parties reserve the right to move the Court for appropriate relief. In particular, respondent would oppose any award for future lost earnings and future pain and suffering. 2 Case 1:24-vv-01101-UNJ Document 27 Filed 04/10/25 Page 5 of 5 HEATHER L. PEARLMAN Deputy Director Torts Branch, Civil Division VORIS E. JOHNSON, JR. Assistant Director Torts Branch, Civil Division s/ JEREMY MAURITZEN JEREMY MAURITZEN Trial Attorney Torts Branch, Civil Division U.S. Department of Justice P.O. Box 146 Benjamin Franklin Station Washington, D.C. 20044-0146 Tel: (202) 307-5710 Jeremy.Mauritzen@usdoj.gov Dated: March 10, 2025 3 ================================================================================ DOCUMENT 4: USCOURTS-cofc-1_24-vv-01101-cl-extra-10842797 Date issued/filed: 2025-04-10 Pages: 1 Docket text: Supplementary opinion from CourtListener cluster 10376209 -------------------------------------------------------------------------------- In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 24-1101V MARY O. LILLY, Chief Special Master Corcoran Petitioner, v. Filed: March 11, 2025 SECRETARY OF HEALTH AND HUMAN SERVICES, Respondent. Paul D. Bekman, Bekman, Marder, Hopper, Malarkey & Perlin, LLC, Baltimore, MD, for Petitioner. Jeremy Mauritzen, U.S. Department of Justice, Washington, DC, for Respondent. DECISION ON DAMAGES1 On July 19, 2024, Mary O. Lilly filed a petition for compensation under the National Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10, et seq.1 (the “Vaccine Act”). Petitioner alleges that she suffered a syncopal episode upon receiving a human papillomavirus (“HPV”) vaccine on June 24, 2022, which resulted in injuries including “a facial injury resulting in swelling and headache, and avulsion of the right, central incisor tooth.” Petition at 2. The case was assigned to the Special Processing Unit of the Office of Special Masters. On January 10, 2025, a Ruling on Entitlement was issued, finding Petitioner entitled to compensation for a Table vasovagal syncope injury. On March 10, 2025, Respondent filed a Proffer on award of compensation (“Proffer”). Respondent represented that Petitioner agrees with the proffered award. Id. at 2. Based on the record as a whole, I find that Petitioner is entitled to an award as stated in the Proffer. 1 Because this Decision contains a reasoned explanation for the action taken in this case, it must be made publicly accessible and will be posted on the United States Court of Federal Claims' website, and/or at https://www.govinfo.gov/app/collection/uscourts/national/cofc, in accordance with the E-Government Act of 2002. 44 U.S.C. § 3501 note (2018) (Federal Management and Promotion of Electronic Government Services). This means the Decision will be available to anyone with access to the internet. In accordance with Vaccine Rule 18(b), Petitioner has 14 days to identify and move to redact medical or other information, the disclosure of which would constitute an unwarranted invasion of privacy. If, upon review, I agree that the identified material fits within this definition, I will redact such material from public access. Pursuant to the terms stated in the attached proffer, Petitioner is awarded a lump sum of $53,418.66 (representing $50,000.00 for pain and suffering, and $3,418.66 for past unreimbursable expenses), to be paid through an ACH deposit to Petitioner’s counsel’s IOLTA account for prompt disbursement to Petitioner. Proffer at 2. This amount represents compensation for all damages that would be available under Section 15(a). Id. The Clerk of Court is directed to enter judgment in accordance with this decision.2 IT IS SO ORDERED. s/Brian H. Corcoran Brian H. Corcoran Chief Special Master 2 Pursuant to Vaccine Rule 11(a), entry of judgment can be expedited by the parties’ joint filing of notice renouncing the right to seek review. 2 IN THE UNITED STATES COURT OF FEDERAL CLAIMS OFFICE OF SPECIAL MASTERS MARY O. LILLY, Petitioner, v. No. 24-1101V Chief Special Master Corcoran SECRETARY OF HEALTH AND ECF HUMAN SERVICES, Respondent. RESPONDENT’S PROFFER ON AWARD OF COMPENSATION On July 19, 2024, Mary O. Lilly (“petitioner”) filed a petition for compensation under the National Childhood Vaccine Injury Act of 1986, 42 U.S.C. §§ 300aa-1 to -34 (“Vaccine Act” or “Act”), alleging that she suffered a syncopal episode following administration of a Human Papillomavirus (“HPV”) vaccine she received on June 24, 2022. Petition at 1. On January 8, 2025, the Secretary of Health and Human Services (“respondent”) filed a Rule 4(c) Report indicating that this case is appropriate for compensation under the terms of the Act for a vasovagal syncope Table injury, and on January 10, 2025, the Chief Special Master issued a Ruling on Entitlement finding petitioner entitled to compensation. ECF No. 13; ECF No. 14. I. Items of Compensation A. Pain and Suffering Respondent proffers that petitioner should be awarded $50,000 in pain and suffering. See 42 U.S.C. § 300aa-15(a)(4). Petitioner agrees. B. Past Unreimbursable Expenses Evidence supplied by petitioner documents that she incurred past unreimbursable expenses related to her vaccine-related injury. Respondent proffers that petitioner should be awarded past unreimbursable expenses in the amount of $3,418.66. See 42 U.S.C. § 300aa- 15(a)(1)(B). Petitioner agrees. These amounts represent all elements of compensation to which petitioner is entitled under 42 U.S.C. § 300aa-15(a). Petitioner agrees. II. Form of the Award Petitioner is a competent adult. Evidence of guardianship is not required in this case. Respondent recommends that the compensation provided to petitioner should be made through a lump sum payment as described below and requests that the Chief Special Master’s decision and the Court’s judgment award the following 1: a lump sum payment of $53,418.66 to be paid through an ACH deposit to petitioner’s counsel’s IOLTA account for prompt disbursement to petitioner. III. Summary of Recommended Payment Following Judgment Lump sum payable to petitioner, Mary O. Lilly: $53,418.66 Respectfully submitted, YAAKOV ROTH Acting Assistant Attorney General C. SALVATORE D’ALESSIO Director Torts Branch, Civil Division 1 Should petitioner die prior to entry of judgment, the parties reserve the right to move the Court for appropriate relief. In particular, respondent would oppose any award for future lost earnings and future pain and suffering. 2 HEATHER L. PEARLMAN Deputy Director Torts Branch, Civil Division VORIS E. JOHNSON, JR. Assistant Director Torts Branch, Civil Division s/ JEREMY MAURITZEN JEREMY MAURITZEN Trial Attorney Torts Branch, Civil Division U.S. Department of Justice P.O. Box 146 Benjamin Franklin Station Washington, D.C. 20044-0146 Tel: (202) 307-5710 Jeremy.Mauritzen@usdoj.gov Dated: March 10, 2025 3 ================================================================================ DOCUMENT 5: USCOURTS-cofc-1_24-vv-01101-cl-extra-11248636 Date issued/filed: 2026-01-30 Pages: 1 Docket text: Supplementary opinion from CourtListener cluster 10782012 -------------------------------------------------------------------------------- In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 24-1101V MARY O. LILLY, Chief Special Master Corcoran Petitioner, v. Filed: December 30, 2025 SECRETARY OF HEALTH AND HUMAN SERVICES, Respondent. Paul D. Bekman, Bekman, Marder, Hopper, Malarkey & Perlin, LLC, Baltimore, MD, for Petitioner. Catherine Elizabeth Stolar, U.S. Department of Justice, Washington, DC, for Respondent. DECISION ON ATTORNEY’S FEES AND COSTS 1 On July 19, 2024, Mary O. Lilly filed a petition for compensation under the National Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10, et seq. 2 (the “Vaccine Act”). Petitioner alleged that she suffered a syncopal episode upon receiving a human papillomavirus vaccine on June 24, 2022. Petition, ECF No. 1. On March 11, 2025, I issued a decision awarding compensation to Petitioner based on the Respondent’s proffer. ECF No. 20. 1 Because this Decision contains a reasoned explanation for the action taken in this case, it must be made publicly accessible and will be posted on the United States Court of Federal Claims' website, and/or at https://www.govinfo.gov/app/collection/uscourts/national/cofc, in accordance with the E-Government Act of 2002. 44 U.S.C. § 3501 note (2018) (Federal Management and Promotion of Electronic Government Services). This means the Decision will be available to anyone with access to the internet. In accordance with Vaccine Rule 18(b), Petitioner has 14 days to identify and move to redact medical or other information, the disclosure of which would constitute an unwarranted invasion of privacy. If, upon review, I agree that the identified material fits within this definition, I will redact such material from public access. 2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for ease of citation, all section references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. § 300aa (2018). Petitioner has now filed a motion for attorney’s fees and costs, requesting an award of $12,112.49 (representing $10,933.00 in fees plus $1,179.49 in costs). Application for Attorneys’ Fees and Costs (“Motion”) filed October 2, 2025, ECF No. 28. Furthermore, Petitioner filed a signed statement representing that no personal out-of-pocket expenses were incurred. ECF No. 28-3. Respondent reacted to the motion on October 7, 2025, indicating that he is satisfied the statutory requirements for an award of attorneys’ fees and costs are met in this case but deferring resolution of the amount to be awarded to my discretion. Respondent’s Response at 2-5, ECF No. 29. Petitioner filed no reply thereafter. I have reviewed the billing records submitted with Petitioner’s request. In my experience, the request appears reasonable, and I find no cause to reduce the requested hours or rates. Furthermore, Petitioner has provided supporting documentation for all claimed costs. ECF No. 28-2. Respondent offered no specific objection to the rates or amounts sought. I find the requested costs reasonable and hereby award them in full. The Vaccine Act permits an award of reasonable attorney’s fees and costs for successful claimants. Section 15(e). Accordingly, I hereby GRANT Petitioner’s Motion for attorney’s fees and costs. Petitioner is awarded attorneys’ fees and costs in the total amount of $12,112.49 (representing $10,933.00 in fees plus $1,179.49 in costs) to be paid through an ACH deposit to Petitioner’s counsel’s IOLTA account for prompt disbursement. In the absence of a timely-filed motion for review (see Appendix B to the Rules of the Court), the Clerk of Court shall enter judgment in accordance with this decision. 3 IT IS SO ORDERED. s/Brian H. Corcoran Brian H. Corcoran Chief Special Master 3 Pursuant to Vaccine Rule 11(a), the parties may expedite entry of judgment by filing a joint notice renouncing their right to seek review. 2